Drugmaker Sanofi said on Thursday it believes the impact from U.S. tariffs to be manageable as it raised its sales growth ...

France's Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by strong ...

Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

Shares of Regeneron Pharmaceuticals Inc. REGN slid 1.35% to $564.64 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.07% to ...

England's women's team received a heroes' welcome after winning Euro 2025, defeating Spain 3-1 on penalties, with Chloe Kelly scoring the winning kick. Government ministers hosted a Downing Street ...

WASHINGTON - The U.S. State Department has called for an immediate investigation into the recent death of a U.S. citizen in Syria, and there have been direct discussions with the Syrian government ...

Review the current Regeneron Pharmaceuticals Inc (REGN:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if REGN is the best investment for you.

What the sigma? Some know “sigma” as the 18th letter of the Greek alphabet but it’s also teen slang for a cool dude.

iShares Biotechnology ETF ETF holdings by MarketWatch. View complete IBB exchange traded fund holdings for better informed ETF trading.